Sharda Cropchem Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 25, 2025, 8:12 pm

Market Cap	7,324 Cr.
Current Price	812
High / Low	887/431
Stock P/E	24.1
Book Value	277
Dividend Yield	0.37 %
ROCE	16.0 %
ROE	12.8 %
Face Value	10.0
PEG Ratio	4.12

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Sharda Cropchem Ltd

Competitors of Sharda Cropchem Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Epigral Ltd	7,929 Cr.	1,838	2,408/1,302	22.6	441	0.34 %	24.9 %	22.3 %	10.0
Dharmaj Crop Guard Ltd	1,031 Cr.	305	390/165	29.6	117	0.00 %	12.0 %	9.24 %	10.0
Bhaskar Agrochemicals Ltd	56.7 Cr.	109	148/55.2	14.5	34.1	0.00 %	21.3 %	24.7 %	10.0
Bhagiradha Chemicals & Industries Ltd	3,813 Cr.	294	448/247	139	53.9	0.03 %	7.44 %	4.91 %	1.00
Best Agrolife Ltd	756 Cr.	320	713/244	10.8	320	0.91 %	12.9 %	9.95 %	10.0
Industry Average	12,070.05 Cr	1,658.35		37.10	435.98	0.31%	15.26%	19.94%	7.25

All Competitor Stocks of Sharda Cropchem Ltd

Quarterly Result

Metric	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	1,434	825	722	1,017	1,482	638	581	632	1,312	785	777	929	1,829
Expenses	1,144	772	656	810	1,164	697	560	563	1,057	708	687	815	1,525
Operating Profit	290	53	65	207	318	-59	21	69	255	77	90	115	303
OPM %	20%	6%	9%	20%	21%	-9%	4%	11%	19%	10%	12%	12%	17%
Other Income	3	20	10	3	7	26	24	12	-2	19	25	1	25
Interest	1	1	0	1	2	1	5	1	0	1	0	0	0
Depreciation	72	55	60	65	68	70	74	69	54	65	69	69	72
Profit before tax	220	18	15	143	255	-105	-34	12	198	31	46	46	256
Tax %	20%	-28%	17%	24%	22%	-15%	-18%	62%	28%	11%	7%	32%	20%
Net Profit	177	23	12	108	199	-89	-28	5	143	27	42	31	204
EPS in Rs	19.62	2.51	1.34	12.01	22.04	-9.82	-3.06	0.51	15.90	3.02	4.70	3.45	22.56

Last Updated: May 31, 2025, 7:50 am

Below is a detailed analysis of the quarterly data for Sharda Cropchem Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Sales, as of Mar 2025, the value is 1,829.00 Cr.. The value appears strong and on an upward trend. It has increased from 929.00 Cr. (Dec 2024) to 1,829.00 Cr., marking an increase of 900.00 Cr..
For Expenses, as of Mar 2025, the value is 1,525.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 815.00 Cr. (Dec 2024) to 1,525.00 Cr., marking an increase of 710.00 Cr..
For Operating Profit, as of Mar 2025, the value is 303.00 Cr.. The value appears strong and on an upward trend. It has increased from 115.00 Cr. (Dec 2024) to 303.00 Cr., marking an increase of 188.00 Cr..
For OPM %, as of Mar 2025, the value is 17.00%. The value appears strong and on an upward trend. It has increased from 12.00% (Dec 2024) to 17.00%, marking an increase of 5.00%.
For Other Income, as of Mar 2025, the value is 25.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Dec 2024) to 25.00 Cr., marking an increase of 24.00 Cr..
For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
For Depreciation, as of Mar 2025, the value is 72.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 69.00 Cr. (Dec 2024) to 72.00 Cr., marking an increase of 3.00 Cr..
For Profit before tax, as of Mar 2025, the value is 256.00 Cr.. The value appears strong and on an upward trend. It has increased from 46.00 Cr. (Dec 2024) to 256.00 Cr., marking an increase of 210.00 Cr..
For Tax %, as of Mar 2025, the value is 20.00%. The value appears to be improving (decreasing) as expected. It has decreased from 32.00% (Dec 2024) to 20.00%, marking a decrease of 12.00%.
For Net Profit, as of Mar 2025, the value is 204.00 Cr.. The value appears strong and on an upward trend. It has increased from 31.00 Cr. (Dec 2024) to 204.00 Cr., marking an increase of 173.00 Cr..
For EPS in Rs, as of Mar 2025, the value is 22.56. The value appears strong and on an upward trend. It has increased from 3.45 (Dec 2024) to 22.56, marking an increase of 19.11.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 5:19 am

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	790	1,061	1,222	1,399	1,707	1,998	2,003	2,396	3,580	4,045	3,163	4,320
Expenses	630	878	941	1,075	1,343	1,621	1,653	1,945	2,884	3,386	2,860	3,724
Operating Profit	160	183	281	324	364	376	350	450	696	659	303	596
OPM %	20%	17%	23%	23%	21%	19%	17%	19%	19%	16%	10%	14%
Other Income	32	25	23	14	9	-22	-12	46	29	40	60	60
Interest	8	9	8	9	15	20	16	16	15	20	24	2
Depreciation	29	23	35	56	70	99	137	170	245	248	267	275
Profit before tax	155	175	261	272	287	235	185	309	464	431	72	378
Tax %	29%	30%	33%	30%	34%	25%	11%	26%	25%	21%	56%	20%
Net Profit	111	123	175	190	191	176	165	229	349	342	32	304
EPS in Rs	12.31	13.63	19.41	21.11	21.14	19.55	18.25	25.40	38.71	37.90	3.53	33.74
Dividend Payout %	16%	18%	21%	19%	19%	20%	22%	20%	16%	16%	85%	27%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	10.81%	42.28%	8.57%	0.53%	-7.85%	-6.25%	38.79%	52.40%	-2.01%	-90.64%	850.00%
Change in YoY Net Profit Growth (%)	0.00%	31.47%	-33.70%	-8.05%	-8.38%	1.60%	45.04%	13.61%	-54.41%	-88.64%	940.64%

Sharda Cropchem Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	15%
5 Years:	17%
3 Years:	6%
TTM:	37%

Compounded Profit Growth
10 Years:	10%
5 Years:	9%
3 Years:	-4%
TTM:	857%

Stock Price CAGR
10 Years:	9%
5 Years:	28%
3 Years:	10%
1 Year:	86%

Return on Equity
10 Years:	15%
5 Years:	12%
3 Years:	10%
Last Year:	13%

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:22 am

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	90	90	90	90	90	90	90	90	90	90	90	90
Reserves	466	564	715	870	1,045	1,194	1,313	1,524	1,822	2,142	2,147	2,410
Borrowings	40	38	2	0	170	0	0	81	47	3	18	8
Other Liabilities	319	354	522	686	914	914	940	1,163	1,779	2,108	1,773	2,217
Total Liabilities	914	1,047	1,329	1,646	2,219	2,198	2,343	2,858	3,738	4,343	4,028	4,725
Fixed Assets	64	88	130	210	226	372	416	544	592	668	708	1,042
CWIP	133	149	210	232	360	220	161	131	212	204	283	0
Investments	174	95	90	61	22	212	116	83	134	32	159	294
Other Assets	542	715	899	1,143	1,611	1,394	1,650	2,099	2,800	3,439	2,878	3,389
Total Assets	914	1,047	1,329	1,646	2,219	2,198	2,343	2,858	3,738	4,343	4,028	4,725

Below is a detailed analysis of the balance sheet data for Sharda Cropchem Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Equity Capital, as of Mar 2025, the value is 90.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 90.00 Cr..
For Reserves, as of Mar 2025, the value is 2,410.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,147.00 Cr. (Mar 2024) to 2,410.00 Cr., marking an increase of 263.00 Cr..
For Borrowings, as of Mar 2025, the value is 8.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 18.00 Cr. (Mar 2024) to 8.00 Cr., marking a decrease of 10.00 Cr..
For Other Liabilities, as of Mar 2025, the value is 2,217.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,773.00 Cr. (Mar 2024) to 2,217.00 Cr., marking an increase of 444.00 Cr..
For Total Liabilities, as of Mar 2025, the value is 4,725.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,028.00 Cr. (Mar 2024) to 4,725.00 Cr., marking an increase of 697.00 Cr..
For Fixed Assets, as of Mar 2025, the value is 1,042.00 Cr.. The value appears strong and on an upward trend. It has increased from 708.00 Cr. (Mar 2024) to 1,042.00 Cr., marking an increase of 334.00 Cr..
For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 283.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 283.00 Cr..
For Investments, as of Mar 2025, the value is 294.00 Cr.. The value appears strong and on an upward trend. It has increased from 159.00 Cr. (Mar 2024) to 294.00 Cr., marking an increase of 135.00 Cr..
For Other Assets, as of Mar 2025, the value is 3,389.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,878.00 Cr. (Mar 2024) to 3,389.00 Cr., marking an increase of 511.00 Cr..
For Total Assets, as of Mar 2025, the value is 4,725.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,028.00 Cr. (Mar 2024) to 4,725.00 Cr., marking an increase of 697.00 Cr..

Notably, the Reserves (2,410.00 Cr.) exceed the Borrowings (8.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Month		Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Cash from Operating Activity +	156	46	197	181	17	556	146	246	267	328	341	604
Cash from Investing Activity +	-145	-19	-113	-104	-160	-351	-59	-282	-205	-112	-393	-510
Cash from Financing Activity +	-22	-24	-89	-38	132	-215	-60	43	-91	-97	-37	-68
Net Cash Flow	-11	3	-6	40	-11	-11	27	8	-29	120	-89	26

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	120.00	145.00	279.00	324.00	194.00	376.00	350.00	369.00	649.00	656.00	285.00	588.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	178	185	156	185	175	191	148	180	177	157	165	173
Inventory Days	62	57	72	74	117	169	96	100	117	130	145	155
Days Payable	130	146	117	179	186	202	167	180	180	172	176	144
Cash Conversion Cycle	111	97	111	81	106	158	77	100	114	115	134	184
Working Capital Days	101	85	95	96	99	130	71	101	105	92	98	129
ROCE %	26%	28%	27%	36%	32%	27%	23%	18%	21%	26%	21%	4%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	74.82%	74.82%	74.82%	74.82%	74.82%	74.82%	74.82%	74.82%	74.82%	74.82%	74.82%	74.82%
FIIs	1.69%	2.16%	2.37%	2.41%	2.14%	2.00%	2.01%	2.06%	2.14%	2.02%	2.52%	3.77%
DIIs	12.84%	12.76%	12.93%	12.61%	12.93%	12.75%	12.29%	12.42%	12.41%	12.87%	12.77%	10.07%
Public	10.64%	10.26%	9.88%	10.15%	10.09%	10.44%	10.87%	10.70%	10.63%	10.29%	9.91%	11.33%
No. of Shareholders	47,898	61,049	58,192	61,106	54,222	52,126	56,483	56,858	61,075	54,436	48,353	58,717

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
HDFC Small Cap Fund - Regular Plan	5,406,610	0.91	244.81	5,406,610	2025-04-22 15:56:53	0%
DSP Small Cap Fund	3,587,791	1.2	162.46	3,587,791	2025-04-22 15:56:53	0%
HDFC Hybrid Equity Fund - Regular Plan	1,977,870	0.4	89.56	1,977,870	2025-04-22 05:57:46	0%
L&T Flexicap Fund - Regular Plan	356,312	0.46	13.34	356,312	2025-04-22 15:56:53	0%
DSP Equity Savings Fund	118,848	0.68	5.38	118,848	2025-04-22 17:25:21	0%
DSP Regular Savings Fund	24,639	0.63	1.12	24,639	2025-04-22 17:25:21	0%
Nippon India Nifty Smallcap 250 Index Fund	15,332	0.07	0.69	15,332	2025-04-22 17:25:21	0%
Motilal Oswal Nifty Smallcap 250 Index Fund	9,582	0.07	0.43	9,582	2025-04-22 17:25:21	0%
SBI Nifty Smallcap 250 Index Fund	7,520	0.07	0.34	7,520	2025-04-22 15:56:53	0%
ICICI Prudential Nifty Smallcap 250 Index Fund	3,579	0.07	0.16	3,579	2025-04-22 15:56:53	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	33.74	3.53	37.90	38.71	25.40
Diluted EPS (Rs.)	33.74	3.53	37.90	38.71	25.40
Cash EPS (Rs.)	64.19	33.15	65.41	65.91	44.30
Book Value[Excl.RevalReserv]/Share (Rs.)	277.16	248.00	247.44	212.01	178.96
Book Value[Incl.RevalReserv]/Share (Rs.)	277.16	248.00	247.44	212.01	178.96
Revenue From Operations / Share (Rs.)	478.81	350.59	448.36	396.78	265.53
PBDIT / Share (Rs.)	72.61	37.98	75.74	78.89	53.50
PBIT / Share (Rs.)	42.17	8.37	48.24	51.70	34.61
PBT / Share (Rs.)	41.93	7.97	47.74	51.46	34.30
Net Profit / Share (Rs.)	33.74	3.54	37.91	38.71	25.41
NP After MI And SOA / Share (Rs.)	33.74	3.53	37.90	38.71	25.40
PBDIT Margin (%)	15.16	10.83	16.89	19.88	20.14
PBIT Margin (%)	8.80	2.38	10.75	13.03	13.03
PBT Margin (%)	8.75	2.27	10.64	12.96	12.91
Net Profit Margin (%)	7.04	1.00	8.45	9.75	9.56
NP After MI And SOA Margin (%)	7.04	1.00	8.45	9.75	9.56
Return on Networth / Equity (%)	12.17	1.42	15.32	18.26	14.19
Return on Capital Employeed (%)	13.88	3.07	18.28	22.73	18.10
Return On Assets (%)	6.44	0.78	7.85	9.33	8.00
Total Debt / Equity (X)	0.00	0.00	0.00	0.01	0.04
Asset Turnover Ratio (%)	0.98	0.75	0.85	0.93	0.80
Current Ratio (X)	1.81	1.86	1.65	1.69	1.84
Quick Ratio (X)	1.32	1.23	1.08	1.16	1.38
Inventory Turnover Ratio (X)	1.81	1.40	1.59	1.96	2.19
Dividend Payout Ratio (NP) (%)	0.00	85.75	16.21	15.49	7.87
Dividend Payout Ratio (CP) (%)	0.00	9.14	9.39	9.10	4.51
Earning Retention Ratio (%)	0.00	14.25	83.79	84.51	92.13
Cash Earning Retention Ratio (%)	0.00	90.86	90.61	90.90	95.49
Interest Coverage Ratio (X)	311.10	94.68	151.52	321.65	174.12
Interest Coverage Ratio (Post Tax) (X)	145.56	9.82	76.83	158.84	83.69
Enterprise Value (Cr.)	4929.40	2811.46	4234.14	5420.45	2398.75
EV / Net Operating Revenue (X)	1.14	0.88	1.05	1.51	1.00
EV / EBITDA (X)	7.52	8.21	6.20	7.62	4.97
MarketCap / Net Operating Revenue (X)	1.19	0.91	1.09	1.55	1.08
Retention Ratios (%)	0.00	14.24	83.78	84.50	92.12
Price / BV (X)	2.06	1.29	1.98	2.90	1.61
Price / Net Operating Revenue (X)	1.19	0.91	1.09	1.55	1.08
EarningsYield	0.05	0.01	0.07	0.06	0.08

After reviewing the key financial ratios for Sharda Cropchem Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 25, the value is 33.74. This value is within the healthy range. It has increased from 3.53 (Mar 24) to 33.74, marking an increase of 30.21.
For Diluted EPS (Rs.), as of Mar 25, the value is 33.74. This value is within the healthy range. It has increased from 3.53 (Mar 24) to 33.74, marking an increase of 30.21.
For Cash EPS (Rs.), as of Mar 25, the value is 64.19. This value is within the healthy range. It has increased from 33.15 (Mar 24) to 64.19, marking an increase of 31.04.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 277.16. It has increased from 248.00 (Mar 24) to 277.16, marking an increase of 29.16.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 277.16. It has increased from 248.00 (Mar 24) to 277.16, marking an increase of 29.16.
For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 478.81. It has increased from 350.59 (Mar 24) to 478.81, marking an increase of 128.22.
For PBDIT / Share (Rs.), as of Mar 25, the value is 72.61. This value is within the healthy range. It has increased from 37.98 (Mar 24) to 72.61, marking an increase of 34.63.
For PBIT / Share (Rs.), as of Mar 25, the value is 42.17. This value is within the healthy range. It has increased from 8.37 (Mar 24) to 42.17, marking an increase of 33.80.
For PBT / Share (Rs.), as of Mar 25, the value is 41.93. This value is within the healthy range. It has increased from 7.97 (Mar 24) to 41.93, marking an increase of 33.96.
For Net Profit / Share (Rs.), as of Mar 25, the value is 33.74. This value is within the healthy range. It has increased from 3.54 (Mar 24) to 33.74, marking an increase of 30.20.
For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 33.74. This value is within the healthy range. It has increased from 3.53 (Mar 24) to 33.74, marking an increase of 30.21.
For PBDIT Margin (%), as of Mar 25, the value is 15.16. This value is within the healthy range. It has increased from 10.83 (Mar 24) to 15.16, marking an increase of 4.33.
For PBIT Margin (%), as of Mar 25, the value is 8.80. This value is below the healthy minimum of 10. It has increased from 2.38 (Mar 24) to 8.80, marking an increase of 6.42.
For PBT Margin (%), as of Mar 25, the value is 8.75. This value is below the healthy minimum of 10. It has increased from 2.27 (Mar 24) to 8.75, marking an increase of 6.48.
For Net Profit Margin (%), as of Mar 25, the value is 7.04. This value is within the healthy range. It has increased from 1.00 (Mar 24) to 7.04, marking an increase of 6.04.
For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.04. This value is below the healthy minimum of 8. It has increased from 1.00 (Mar 24) to 7.04, marking an increase of 6.04.
For Return on Networth / Equity (%), as of Mar 25, the value is 12.17. This value is below the healthy minimum of 15. It has increased from 1.42 (Mar 24) to 12.17, marking an increase of 10.75.
For Return on Capital Employeed (%), as of Mar 25, the value is 13.88. This value is within the healthy range. It has increased from 3.07 (Mar 24) to 13.88, marking an increase of 10.81.
For Return On Assets (%), as of Mar 25, the value is 6.44. This value is within the healthy range. It has increased from 0.78 (Mar 24) to 6.44, marking an increase of 5.66.
For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
For Asset Turnover Ratio (%), as of Mar 25, the value is 0.98. It has increased from 0.75 (Mar 24) to 0.98, marking an increase of 0.23.
For Current Ratio (X), as of Mar 25, the value is 1.81. This value is within the healthy range. It has decreased from 1.86 (Mar 24) to 1.81, marking a decrease of 0.05.
For Quick Ratio (X), as of Mar 25, the value is 1.32. This value is within the healthy range. It has increased from 1.23 (Mar 24) to 1.32, marking an increase of 0.09.
For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.81. This value is below the healthy minimum of 4. It has increased from 1.40 (Mar 24) to 1.81, marking an increase of 0.41.
For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 85.75 (Mar 24) to 0.00, marking a decrease of 85.75.
For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 9.14 (Mar 24) to 0.00, marking a decrease of 9.14.
For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 14.25 (Mar 24) to 0.00, marking a decrease of 14.25.
For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 90.86 (Mar 24) to 0.00, marking a decrease of 90.86.
For Interest Coverage Ratio (X), as of Mar 25, the value is 311.10. This value is within the healthy range. It has increased from 94.68 (Mar 24) to 311.10, marking an increase of 216.42.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 145.56. This value is within the healthy range. It has increased from 9.82 (Mar 24) to 145.56, marking an increase of 135.74.
For Enterprise Value (Cr.), as of Mar 25, the value is 4,929.40. It has increased from 2,811.46 (Mar 24) to 4,929.40, marking an increase of 2,117.94.
For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.14. This value is within the healthy range. It has increased from 0.88 (Mar 24) to 1.14, marking an increase of 0.26.
For EV / EBITDA (X), as of Mar 25, the value is 7.52. This value is within the healthy range. It has decreased from 8.21 (Mar 24) to 7.52, marking a decrease of 0.69.
For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.19. This value is within the healthy range. It has increased from 0.91 (Mar 24) to 1.19, marking an increase of 0.28.
For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 14.24 (Mar 24) to 0.00, marking a decrease of 14.24.
For Price / BV (X), as of Mar 25, the value is 2.06. This value is within the healthy range. It has increased from 1.29 (Mar 24) to 2.06, marking an increase of 0.77.
For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.19. This value is within the healthy range. It has increased from 0.91 (Mar 24) to 1.19, marking an increase of 0.28.
For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.05, marking an increase of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Sharda Cropchem Ltd as of June 26, 2025 is: 686.12

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of June 26, 2025, Sharda Cropchem Ltd is Overvalued by 15.50% compared to the current share price 812.00

Intrinsic Value of Sharda Cropchem Ltd as of June 26, 2025 is: 726.21

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of June 26, 2025, Sharda Cropchem Ltd is Overvalued by 10.57% compared to the current share price 812.00

Last 5 Year EPS CAGR: 5.84%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 24.08%, which is a positive sign. The company has higher reserves (1,351.00 cr) compared to borrowings (33.92 cr), indicating strong financial stability. The company has shown consistent growth in sales (67.75 cr) and profit (268.67 cr) over the years.	The stock has a high average Working Capital Days of 100.17, which may not be favorable. The stock has a high average Cash Conversion Cycle of 115.67, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Sharda Cropchem Ltd:
1. Net Profit Margin: 7.04%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 13.88% (Industry Average ROCE: 15.26%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 12.17% (Industry Average ROE: 19.94%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 145.56
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.32
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 24.1 (Industry average Stock P/E: 37.1)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Sharda Cropchem Ltd. is a Public Limited Listed company incorporated on 12/03/2004 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L51909MH2004PLC145007 and registration number is 145007. Currently Company is involved in the business activities of Wholesale of fertilizers and agrochemical products. Company's Total Operating Revenue is Rs. 3661.10 Cr. and Equity Capital is Rs. 90.22 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Agro Chemicals/Pesticides	Prime Business Park, Dashrathlal Joshi Road, Mumbai Maharashtra 400056	co.sec@shardaintl.com http://www.shardacropchem.com

Management
Name	Position Held
Mr. Ramprakash V Bubna	Chairman & Managing Director
Mrs. Sharda R Bubna	Whole Time Director
Mr. Ashish R Bubna	Whole Time Director
Mr. Manish R Bubna	Whole Time Director
Mr. M S Sundara Rajan	Independent Director
Mr. Shitin Desai	Independent Director
Mr. Shobhan Thakore	Independent Director
Ms. Sonal Desai	Independent Director
Mr. H S Upendra Kamath	Addnl. & Ind.Director
Mr. Vinod Kathuria	Addnl. & Ind.Director
Mr. Shalin Divatia	Addnl. & Ind.Director

FAQ

What is the intrinsic value of Sharda Cropchem Ltd?

Sharda Cropchem Ltd's intrinsic value (as of 25 June 2025) is ₹686.12 — 15.50% lower the current market price of 812.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 7,324 Cr. market cap, FY2025-2026 high/low of ₹887/431, reserves of 2,410 Cr, and liabilities of 4,725 Cr.

What is the Market Cap of Sharda Cropchem Ltd?

The Market Cap of Sharda Cropchem Ltd is 7,324 Cr..

What is the current Stock Price of Sharda Cropchem Ltd as on 25 June 2025?

The current stock price of Sharda Cropchem Ltd as on 25 June 2025 is 812.

What is the High / Low of Sharda Cropchem Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Sharda Cropchem Ltd stocks is ₹887/431.

What is the Stock P/E of Sharda Cropchem Ltd?

The Stock P/E of Sharda Cropchem Ltd is 24.1.

What is the Book Value of Sharda Cropchem Ltd?

The Book Value of Sharda Cropchem Ltd is 277.

What is the Dividend Yield of Sharda Cropchem Ltd?

The Dividend Yield of Sharda Cropchem Ltd is 0.37 %.

What is the ROCE of Sharda Cropchem Ltd?

The ROCE of Sharda Cropchem Ltd is 16.0 %.

What is the ROE of Sharda Cropchem Ltd?

The ROE of Sharda Cropchem Ltd is 12.8 %.

What is the Face Value of Sharda Cropchem Ltd?

The Face Value of Sharda Cropchem Ltd is 10.0.